Analysis of Adverse Drug Events of Opioids in the United States
View ORCID ProfileEdward Y. Liu, View ORCID ProfileKenneth L. McCall, View ORCID ProfileBrian J. Piper
doi: https://doi.org/10.1101/2022.10.21.22281281
Edward Y. Liu
aDepartment of Medical Education, Geisinger Commonwealth School of Medicine
Kenneth L. McCall
bDepartment of Pharmacy Practice, Binghamton University
Brian J. Piper
aDepartment of Medical Education, Geisinger Commonwealth School of Medicine
cCenter for Pharmacy Innovation & Outcomes, Geisinger
Posted October 22, 2022.
Analysis of Adverse Drug Events of Opioids in the United States
Edward Y. Liu, Kenneth L. McCall, Brian J. Piper
medRxiv 2022.10.21.22281281; doi: https://doi.org/10.1101/2022.10.21.22281281
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2942)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4583)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2917)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4353)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6938)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)